According to a recent LinkedIn post from Forge Biologics, the company recently hosted The Ohio State University Gene Therapy Institute at its facility, known as the Hearth, to discuss how academic research can be translated into scalable manufacturing. The post highlights the depth of gene therapy expertise in Columbus and emphasizes close ties among research centers, hospitals, and biotech companies in the region.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests Forge is positioning itself as a central player within this local gene therapy ecosystem, potentially strengthening its pipeline of partnerships and contract work as academic projects progress toward clinical and commercial stages. For investors, this type of ecosystem engagement may signal future demand for Forge’s manufacturing capabilities and could support longer-term revenue visibility if collaborations deepen into formal business relationships.

